Former FDA Commissioner Stephen Hahn joins Blackfynn’s board of directors – PhillyVoice.com

Related Articles:

• MJFF and Blackfynn Collaborate on Parkinson’s Study to Discover Biomarkers October 26, 2018 The Michael J. Fox Foundation (MJFF) and Blackfynn are joining forces to make optimal use of an initiative that could uncover Parkinson’s disease biomarkers and bring about new therapies. Called the Parkinson’s Progression Markers Initiative (PPMI), the MJFF-backed effort is an ongoing observational study of more than 1,300 volunteer participants both with and without Parkinson’s to validate biomarkers and, over…
• Blackfynn announces an expanded partnership with The Michael J. Fox Foundation, extends its neurodegenerative disease data ecosystem and Dr. Karl Kieburtz joins as Head of Clinical Development - P&T Community March 21, 2019 Blackfynn announces an expanded partnership with The Michael J. Fox Foundation, extends its neurodegenerative disease data ecosystem and Dr. Karl Kieburtz joins as Head of Clinical Development  P&T CommunityPHILADELPHIA, March 21, 2019 /PRNewswire/ -- Blackfynn, a technology-driven, life-sciences company building the gold-standard data ecosystem in ...
• Call for Applications to the Parkinson Canada Board of Directors March 25, 2019 The Governance & Nominating Committee is calling for candidates for the Parkinson Canada Board of Directors. There are two (2) vacancies to be filled for this year. All Directors will be elected for a three (3) year term (2019 – 2022). Call for Applications Two vacancies on the Parkinson Canada Board of Directors Apply by:April 10, 2019 Download a detailed…
• Former Washington County commissioner dies - WJHG-TV May 27, 2019 Former Washington County commissioner dies  WJHG-TVA former Washington County commissioner has died after a battle with Parkinson's Disease.
• Ed Rendell announces he's battling Parkinson's disease - PhillyVoice.com June 18, 2018 PhillyVoice.comEd Rendell announces he's battling Parkinson's diseasePhillyVoice.comEd Rendell made his three-year battle with Parkinson's disease public on Monday, saying a combination of medicine and physical therapy have stabilized the neurodegenerative disorder. Rendell, 74 ... He also encourages physical therapy and exercise.and more »
• Rosalind B. Hahn - Hartford Courant May 28, 2019 Rosalind B. Hahn  Hartford CourantHahn, Rosalind (Roz) Minsky Bobrow passed away, peacefully, on Sunday, May 26, 2019 at home with her husband, Howard Hahn, by her side. Roz was raised ...
• Meet the Newest Davis Phinney Foundation Leaders in Parkinson’s December 8, 2020 We are delighted to announce the creation of The Davis Phinney Foundation Inclusion, Diversity, Equity, and Access (IDEA) Advisory Board. This team of renowned healthcare providers and leaders in the fields of equity and inclusion will play an integral role in our work to better understand and change deeply rooted inequities in healthcare that black, brown, and indigenous communities; LGBTQ+;…
• Plasma Infusions from Young Donors Carry Risks, No Benefit, FDA Warns February 22, 2019 The U.S. Food and Drug Administration (FDA) is warning consumers, physicians, and health care providers that infusions of plasma from young donors for the treatment of normal aging or diseases such as Parkinson’s or Alzheimer’s are not approved and have not undergone the agency’s rigorous testing for efficacy and safety. As a result, such a method — also used for…
• FDA and FTC Issue Joint Warning Letter to Company Selling Unproven CBD Products October 24, 2019 The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have issued a joint warning letter to Rooted Apothecary LLC, of Naples, Florida for illegally selling and advertising unapproved cannabidiol (CBD) products online with unsubstantiated health claims. The warning letter states that Rooted Apothecary falsely marketed their CBD products on their social media website and online store claiming…
• Welcome New Members of the Davis Phinney Foundation Board of Directors November 1, 2019 We are pleased to announce two new members to our Board of Directors. Brandon Halcott and Jeff Parr bring their personal missions of helping people live well with Parkinson’s to the Foundation. We look forward to the momentum their strategic leadership will bring in 2020 and beyond.  Brandon Halcott is the co-founder and President of Tru Family Dental, a dental…
• Blackfynn expands partnership with the Michael J. Fox Foundation - Technical.ly March 27, 2019 Blackfynn expands partnership with the Michael J. Fox Foundation  Technical.lyThe data analytics company's cofounder and president, Amanda Christini, said the company is working to “massively accelerate discovery in the field” of ...
• Blackfynn Builds Therapeutic Pipeline with Option to a Phase 3-Ready Drug for Parkinson's - Daily Local News February 18, 2021 Blackfynn Builds Therapeutic Pipeline with Option to a Phase 3-Ready Drug for Parkinson's  Daily Local News
• FDA: Arizona Company Promoting Unapproved Stem Cell Products for Lyme Disease, Diabetes, Other Serious Conditions June 5, 2019 The Food and Drug Administration (FDA) has sent an untitled letter to R3 Stem Cell, LLC of Scottsdale, Arizona for marketing unapproved stem cell products to treat a variety of diseases and conditions. The FDA has not approved the products offered by R3 Stem Cell, LLC and its affiliated centers or clinics throughout the United States. The untitled letter describes…
• Treatment with Stalevo and Comtan Does Not Raise Prostate Cancer Risk, FDA Finds August 22, 2019 A review by the U.S. Food and Drug Administration (FDA) found that Parkinson’s patients treated with medications containing entacapone are at no increased risk of prostate cancer. As such, the agency stands by its current recommendations for the use of Stalevo (entacapone/carbidopa/levodopa) and Comtan (entacapone; brand name is Comtess elsewhere) to ease motor problems in Parkinson’s disease. The FDA review was conducted after the findings…
• Benefits of Acadia’s Nuplazid Outweigh Risks for Parkinson’s Psychosis Patients, FDA Reports September 24, 2018 Nearly half a year after news reports surfaced about deaths allegedly linked to Nuplazid (pimavanserin) — a therapy for Parkinson’s patients with disease-related psychosis — the U.S. Food and Drug Administration says it could not find any new or unexpected safety concerns with the controversial treatment. The agency said in a Sept. 20 press release that “after a thorough review, the FDA’s…
• Press Announcements > Statement from FDA Commissioner Scott Gottlieb, MD and Jeff Shuren, MD, Director of the Center for Devices and Radiological Health, on efforts to evaluate materials in medical devices to address potential safety… March 15, 2019 Press Announcements > Statement from FDA Commissioner Scott Gottlieb, MD and Jeff Shuren, MD, Director of the Center for Devices and Radiological Health, on efforts to evaluate materials in medical devices to address potential safety questions  FDA.govThe FDA is working to further evaluate materials like metals that are used in medical devices to learn more about how these materials interact with…
• Welcome to Our New Davis Phinney Foundation Board Members November 16, 2018 As 2018 quickly comes to a close, we’d like to announce three new members of our Board of Directors. We’re excited to have them join us and to benefit from their years of diverse experience so we can continue to help people with Parkinson’s live well today. You can read their full bios, along with those of our other board…
• FTC Warns Companies Against Unsubstantiated Advertising of CBD Products for Fibromyalgia September 17, 2019 The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol (CBD), cautioning them that making unsubstantiated claims about the health benefits of CBD could lead to legal action. The agency “urges the companies to review all claims made for their products, including consumer testimonials, to ensure they are supported by competent and…
• The at-home health test kits to have on your radar - PhillyVoice.com February 4, 2019 The at-home health test kits to have on your radar  PhillyVoice.comTest for everything from food sensitivity to gut health and even STDs in the comfort of your own home.
• Parkinson's: four unusual signs you may be at risk - PhillyVoice.com May 24, 2019 Parkinson's: four unusual signs you may be at risk  PhillyVoice.comDo you move around a lot during your sleep? Or have you lost your sense of smell? New insights suggest that these might be the early signs of changes in the ...
• Parkinson's may no longer be a matter of opinion - PhillyVoice.com May 27, 2019 Parkinson's may no longer be a matter of opinion  PhillyVoice.comWhen it comes to Parkinson's disease watching how a patient walks, talks and draws remain among the key activities neurologists use to make a diagnosis.
• Appendix removal is associated with higher rate of Parkinson’s disease, new study says - PhillyVoice.com May 9, 2019 Appendix removal is associated with higher rate of Parkinson’s disease, new study says  PhillyVoice.comPatients who had appendectomies are three times more likely to develop Parkinson's disease, according to the largest study ever focused on the relationship ...